Conditions: Allergic Rhinitis Chronic Urticaria
Keywords: Xyzal Levocetirizine Allergy Children Seasonal Allergies
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 173
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine the safety of the oral formulation of levocetirizine in children ages 1 to less than 6 years old who suffer from allergic rhinitis or chronic urticaria of unknown origin.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Levocetirizine intervention 2: Placebo
Intervention descriptions: intervention 1: Levocetirizine dihydrochloride 1.25 mg oral drops formulation (5 drops containing 5mg/mL) dosed twice a day for 2 weeks intervention 2: Placebo oral drops (5 drops) dosed twice a day for 2 weeks.

Protocol document: